<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">RUDN Journal of Medicine</journal-id><journal-title-group><journal-title xml:lang="en">RUDN Journal of Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российского университета дружбы народов. Серия: Медицина</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-0245</issn><issn publication-format="electronic">2313-0261</issn><publisher><publisher-name xml:lang="en">Peoples’ Friendship University of Russia named after Patrice Lumumba (RUDN University)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">37168</article-id><article-id pub-id-type="doi">10.22363/2313-0245-2023-27-4-419-427</article-id><article-id pub-id-type="edn">CZEBQX</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>PHYSIOLOGY. EXPERIMENTAL PHYSIOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ФИЗИОЛОГИЯ. ЭКСПЕРИМЕНТАЛЬНАЯ ФИЗИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Blood pressure status in patients with metabolic syndrome</article-title><trans-title-group xml:lang="ru"><trans-title>Состояние артериального давления у пациентов с метаболическим синдромом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1510-0982</contrib-id><name-alternatives><name xml:lang="en"><surname>Sorout</surname><given-names>Jitender</given-names></name><name xml:lang="ru"><surname>Сороут</surname><given-names>Д.</given-names></name></name-alternatives><email>nehasaboo8@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8947-2036</contrib-id><name-alternatives><name xml:lang="en"><surname>Kacker</surname><given-names>Sudhanshu</given-names></name><name xml:lang="ru"><surname>Какер</surname><given-names>С.</given-names></name></name-alternatives><email>nehasaboo8@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3874-1459</contrib-id><name-alternatives><name xml:lang="en"><surname>Saboo</surname><given-names>Neha</given-names></name><name xml:lang="ru"><surname>Сабу</surname><given-names>Н.</given-names></name></name-alternatives><email>nehasaboo8@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-2499-6500</contrib-id><name-alternatives><name xml:lang="en"><surname>Kumar</surname><given-names>Munesh</given-names></name><name xml:lang="ru"><surname>Кумар</surname><given-names>М.</given-names></name></name-alternatives><email>nehasaboo8@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Rajasthan University of Health Sciences College of Medical Sciences</institution></aff><aff><institution xml:lang="ru">Колледж медицинских наук Раджастанского университета медицинских наук</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2023-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2023</year></pub-date><volume>27</volume><issue>4</issue><issue-title xml:lang="en">PHYSIOLOGY. EXPERIMENTAL PHYSIOLOGY</issue-title><issue-title xml:lang="ru">ФИЗИОЛОГИЯ. ЭКСПЕРИМЕНТАЛЬНАЯ ФИЗИОЛОГИЯ</issue-title><fpage>419</fpage><lpage>427</lpage><history><date date-type="received" iso-8601-date="2023-12-22"><day>22</day><month>12</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Sorout J., Kacker S., Saboo N., Kumar M.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Сороут Д., Какер С., Сабу Н., Кумар М.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Sorout J., Kacker S., Saboo N., Kumar M.</copyright-holder><copyright-holder xml:lang="ru">Сороут Д., Какер С., Сабу Н., Кумар М.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.rudn.ru/medicine/article/view/37168">https://journals.rudn.ru/medicine/article/view/37168</self-uri><abstract xml:lang="en"><p style="text-align: justify;">Relevance. Metabolic syndrome (MetS) is existence of many abnormalities, such as abdominal obesity, hypertension, dyslipidemia, and glucose intolerance. The occurrence of MetS in hypertensive people is linked to poorly managed hypertension. One of the parameters for the diagnosis of the syndrome is the presence of increased blood pressure; nevertheless, research shows that MetS patients are likely to experience hypertension often. Materials and Methods. 300 metabolic subjects were selected from the medicine OPD as study participants based on the joint interim statement’s 2009 definition of the metabolic syndrome. They were divided into three groups (normotensive, pre-hypertensive, and hypertensive) based on blood pressure readings that met the American Heart Association’s (AHA) Asian blood pressure criteria. The following parameters were recorded for data collection: anthropometric (Weight, Height, Body Mass Index Waist Hip Ratio), Blood pressure, biochemical (Fasting blood glucose, Lipid profile parameters). Results and Discussion. According to the resting blood pressure readings, out of 300 metabolic syndrome participants, 37 were normotensive [male (40.54 %); female (59.45 %)], 115 were pre-hypertensive [male (58.26 %); female (41.74 %), and 148 were hypertensive [male (52.7 %); female (47.3 %)]. In several parameters, there was no such significant difference between male and female participants across all groups. However, the levels of blood total cholesterol, triglycerides, and low-density lipoprotein were considerably greater in hypertensive and pre-hypertensive metabolic participants than in normotensive subjects, while the levels of high-density lipoprotein were lower. Conclusion. Study findings suggest, hypertension and pre-hypertension were more prevalent in the group with metabolic syndrome. Additionally, hypertensives have a higher chance of manifesting dyslipidemia.</p></abstract><trans-abstract xml:lang="ru"><p style="text-align: justify;">Актуальность. Метаболический синдром (МетС) - это наличие множества отклонений, таких как абдоминальное ожирение, гипертония, дислипидемия и непереносимость глюкозы. Возникновение МетС у людей с гипертонической болезнью связано с плохо управляемой гипертонией. Одним из параметров диагностики синдрома является наличие повышенного артериального давления; тем не менее, исследования показывают, что пациенты с МетС часто страдают гипертонией. Материалы и методы. 300 субъектов, страдающих обменом веществ, были выбраны из медицинского OPD в качестве участников исследования на основе определения МетС, содержащегося в совместном промежуточном заявлении 2009 г. Они были разделены на три группы (нормотензивные, предгипертензивные и гипертонические) на основании показаний артериального давления, соответствующих азиатским критериям артериального давления Американской кардиологической ассоциации (AHA). Для сбора данных записывались следующие параметры: антропометрические (вес, рост, индекс массы тела, соотношение талии и бедер), кровяное давление, биохимические (глюкоза в крови натощак, параметры липидного профиля). Результаты и обсуждение. Согласно показаниям артериального давления в покое, из 300 участников МетС 37 имели нормотензивное давление [мужчины (40,54 %); женщины (59,45 %)], 115 были в предгипертензивном состоянии [мужчины (58,26 %); женщины (41,74 %), 148 человек страдали гипертонической болезнью [мужчины (52,7 %); женщины (47,3 %)]. По нескольким параметрам не было столь существенной разницы между участниками мужского и женского пола во всех группах. Однако уровни общего холестерина, триглицеридов и липопротеинов низкой плотности в крови были значительно выше у гипертонических и предгипертонических участников метаболического процесса, чем у нормотензивных субъектов, тогда как уровни липопротеинов высокой плотности были ниже. Выводы. Результаты исследования показывают, что гипертония и предгипертензия более распространены в группе с метаболическим синдромом. Кроме того, у гипертоников выше вероятность проявления дислипидемии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>blood pressure</kwd><kwd>hypertension</kwd><kwd>metabolic syndrome</kwd><kwd>pre-hypertension</kwd><kwd>risk factors</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>артериальное давление</kwd><kwd>артериальная гипертензия</kwd><kwd>метаболический синдром</kwd><kwd>гипертония</kwd><kwd>факторы риска</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Mohanan PP. Metabolic syndrome in Indian population: public health implication. Hypertens J. 2016;2:1-6.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Deedwania PC, Gupta R. Management issues in the metabolic syndrome. J Assoc Physicians India. 2006; 54: 797-810.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415-28. doi: 10.1016/S0140-6736(05)66378-7</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>van der Pal KC, Koopman ADM, Lakerveld J, van der Heijden AA, Elders PJ, Beulens JW, Rutters F. The association between multiple sleep-related characteristics and the metabolic syndrome in the general population: the New Hoorn study. Sleep Med. 2018;52:51-57. doi: 10.1016/j.sleep.2018.07.022</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-52. doi: 10.1161/01.HYP.0000107251.49515.c2</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Arcucci O, de Simone G, Izzo R, Rozza F, Chinali M, Rao MA, Bodenizza C, De Luca N, Trimarco B. Association of suboptimal blood pressure control with body size and metabolic abnormalities. J Hypertens. 2007;25(11):2296-300. doi: 10.1097/ HJH.0b013e3282e9a9e4</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Chimonas T, Karagiannis A, Athyros VG, Achimastos A, Elisaf M, Panagiotakos DB. Assessing The Treatment Effect in Metabolic Syndrome without Perceptible diabeTes (ATTEMPT) Collaborative Group. Blood pressure levels constitute the most important determinant of the metabolic syndrome in a Mediterranean population: a discrimination analysis. Metab Syndr Relat Disord. 2010;8(6):523-9. doi: 10.1089/met.2010.0023</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, Reid J, Van Zwieten PA. The sympathetic nervous system and the metabolic syndrome. J Hypertens. 2007;25(5):909-20. doi: 10.1097/ HJH.0b013e328048d004</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Endothelial dysfunction in metabolic syndrome: Prevalence, pathogenesis and management. NutrMetab Cardiovasc Dis. 2010;20:140-46. doi: 10.1016/j.numecd.2009.08.006</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Yadav R, Yadav RK, Khadgawat R, Pandey RM, Upadhyay AD, Mehta N. Randomized Controlled Trial of A 12-Week Yoga-Based (Including Diet) Lifestyle vs. Dietary Intervention on Cardio-Metabolic Risk Factors and Continuous Risk Score in Indian Adults with Metabolic Syndrome. Behav Med. 2020;46(1):9-20. doi: 10.1080/08964289.2018.1538098</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>National Health and Nutrition Examination Survey (NHANES)- Anthropometry Procedures Manual, January 2007. https://wwwn.cdc.gov/nchs/data/nhanes/20152016/manuals/2016_Anthropometry_Procedures_Manual.pdf. [Acessed on 13 June 2023]</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555-76</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol. 1969;22(2):158-61. doi: 10.1136/jcp.22.2.158</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20(4):470-5</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28(10):2077-80.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Huang Y, Cai X, Liu C, Zhu D, Hua J, Hu Y, Peng J, Xu D. Prehypertension and the risk of coronary heart disease in Asian and Western populations: a meta-analysis. J Am Heart Assoc. 2015;4(2): e001519. doi: 10.1161/JAHA.114.001519</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Mohan V, Rao GHR. Type 2 Diabetes in South Asains. 1st ed. New Delhi: South Asian Society on Atherosclerosis and Thrombosis. 2007. New Delhi. India. 435 p.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Misra A, Khurana L. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Metab Syndr Relat Disord. 2009;7(6):497-514. doi: 10.1089/met.2009.0024</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157-63. doi: 10.1016/ S0140-6736(03)15268-3</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ. 1995;311(6998):158-61. doi: 10.1136/bmj.311.6998.158</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Lv Y, Yao Y, Ye J. Association of Blood Pressure with Fasting Blood Glucose Levels in Northeast China: A Cross-Sectional Study. Sci Rep. 2018; (8):7917. doi: 10.1038/s41598-018-26323-6</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2016;12(3):144-53. doi: 10.1038/nrendo.2015.216</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>NIH ATP 3 Guidelines and overview of antilipid medications: http://www.nhlbi.nih.gov/health-pro/guidelines/current/cholesterol guidelines/quick-desk-reference-html [Acessed on 13 June 2023].</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Choudhury KN, Mainuddin AK, Wahiduzzaman M, Islam SM. Serum lipid profile and its association with hypertension in Bangladesh. Vasc Health Risk Manag. 2014;10:327-32. doi: 10.2147/VHRM.S61019</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Lewis GF, Uffelman KD, Szeto LW, Steiner G. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes. 1993;42(6):833-42. doi: 10.2337/diab.42.6.833</mixed-citation></ref></ref-list></back></article>
